Febuxostat is a medicine used to treat high uric acid levels, which can cause gout. It works by blocking an enzyme that produces uric acid. It's a common treatment for people who have gout.
Every report comes from a Lived member, sent anonymously.
Have you tried Uloric (Febuxostat) for Gout?
Febuxostat, sold as Uloric and as a generic, is a prescription tablet that lowers uric acid in adults with gout. Gout is a type of arthritis in which uric acid, a natural waste product, builds up in the joints and causes sudden attacks of pain, redness, swelling and heat. Because of a heart safety finding, it is approved only for people who cannot use allopurinol, the usual first-line medicine, or whose uric acid stays too high on the highest workable allopurinol dose. It prevents future attacks rather than relieving one under way, and it is not recommended for high uric acid that is not causing gout.
Febuxostat belongs to a group of medicines called xanthine oxidase inhibitors. Xanthine oxidase is the enzyme the body uses to make uric acid, so blocking it lowers the amount produced. When uric acid stays low for months, the urate stored in and around the joints is gradually drawn back out, and attacks become less frequent. The same shift is why flares often increase at first.
Febuxostat is taken as a tablet once a day, with or without food. Treatment usually starts at 40 mg. A blood test can check uric acid as early as two weeks later, and if the level is not below 6 mg/dL (milligrams per deciliter), the usual treatment target in gout, the dose may be raised to 80 mg. People with severe kidney disease are kept at the lower dose. When febuxostat is started, a second medicine to prevent flares is recommended for several months, usually colchicine or a nonsteroidal anti-inflammatory drug (NSAID) such as naproxen. Keep taking febuxostat through flares, and talk with the prescriber before stopping.
The more common side effects are nausea, joint pain and rash, and routine blood tests sometimes show raised liver enzymes. Serious liver injury is rare but has been fatal in some cases, so liver tests are done before treatment starts. Yellowing of the skin or eyes, dark urine or pain in the upper right abdomen should be reported to the prescriber right away. Severe skin reactions are also rare: a spreading rash, blistering or peeling skin, sores of the lips, mouth or eyes, or fever with a rash means stopping febuxostat and contacting the prescriber promptly.
Febuxostat carries a boxed warning, the most prominent warning the US Food and Drug Administration requires. In a large study of people with gout and existing heart disease, those taking febuxostat had a higher rate of death from heart causes, mostly sudden cardiac death, than those taking allopurinol. Rates of nonfatal heart attack and stroke were similar. Anyone with heart disease should weigh this trade-off with the prescriber. Chest pain, shortness of breath, sudden weakness on one side of the body or slurred speech can signal a heart attack or stroke: call 911. Febuxostat must not be combined with azathioprine, an immune-suppressing medicine used after kidney transplants and for severe rheumatoid arthritis, or mercaptopurine, a chemotherapy drug for leukemia, because it can raise them to toxic levels. It also needs caution with theophylline, a medicine for asthma and other lung diseases.
Uric acid falls within weeks, but fewer attacks can take several months to show, so flare-prevention medicine usually continues for three to six months. Blood tests track uric acid until it stays below target. Febuxostat controls gout but does not cure it, so it is usually taken long term. If uric acid stays high or side effects become a problem, the prescriber can discuss other ways to lower it.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Uloric (Febuxostat), what you've noticed, or ask the community a question.